Physician profile
Brett Levitt
NPI 1770177370
$909.68
in general payments reported to CMS, 2019-2025
7 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.91 · 2022: $44.89 · 2023: $107 · 2024: $349 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $482.88 | 2023-2025 | Titan |
| Boston Scientific Corporation | $137.46 | 2023-2025 | General - Erectile Dysfunction |
| Revance Therapeutics, INC. | $108.76 | 2024 | Daxxify |
| Tolmar, INC. | $96.78 | 2023-2025 | Jatenzo |
| Acerus Pharmaceuticals Corporation | $44.89 | 2022 | |
| Urovant Sciences INC | $19.58 | 2021 | |
| Clarus Therapeutics INC. | $19.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Levitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.